| Name | Title | Contact Details |
|---|
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.
Jewish Hospital and St. Mary's HealthCare, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Louisville, KY. To find more information about Jewish Hospital and St. Mary's HealthCare, Inc., please visit www.jhsmh.org
IMDS (Innovative Medical Device Solutions) provides comprehensive product development and supply chain management solutions for medical device companies, with a focus on the orthopedic industry. IMDS is the integration of the following companies: Leis
Burke County Hospital Auxiliary, Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Waynesboro, GA. To find more information about Burke County Hospital Auxiliary, Inc, please visit www.burkemedical.net
Premier Diagnostic Health Services Inc. (“Premier”, “PDH” or the “Company”) is a Canadian corporation with its head office in Burnaby, British Columbia. PDH designs, finances, builds and operates free standing diagnostic imaging centres with no outside affiliation in Canada, and joint venture, diagnostic imaging centres in China with local hospitals. PDH specializes in PET/CT and MRI scanning for the detection and evaluation of cancer, heart disease and neurological disorders